The endemicity of an area in terms of micronutrient deficiencies as a criterion for compounding a basic vitamin-mineral complex for the periconceptional period
The authors have carried out a systems analysis of the data available in the current literature on the effect of micronutrients, such as iodine, polyunsaturated fatty acids, folic acid, and vitamin D, on a woman’s reproductive health. Due to its geographical location, climatic features, and eating habits, our country has the proven deficiency of a number of micronutrients that play an important role in the periconceptional period. These micronutrients include iodine, polyunsaturated fatty acids, folic acid, and vitamin D. The content of micronutrients should not exceed the physiological daily requirement in the basic complexes intended for the prevention of deficiency, The excessive content of components can cause undesirable reactions and contribute to the allergization of newborns. In clinically pronounced deficiency, the basal complex can be combined with a monocomponent vitamin preparation for the targeted correction of vitamin and mineral status.Shikh E.V., Makhova A.A.
Keywords
vitamin D
iodine
folic acid
polyunsaturated fatty acids
basic complex
References
1. Lowensohn R.I., Stadler D.D., Naze C. Current concepts of maternal nutrition. Obstet. Gynecol. Surv. 2016; 71(7): 413-26.
2. Ших Е.В., Махова А.А. Витаминно-минеральный комплекс при беременности. М.: ГЭОТАР-Медиа; 2016. 349с. [Shikh E.V., Makhova A.A. Vitamin and mineral complex during pregnancy. Moscow: GEOTAR-Media; 2016. 349p. (in Russian)]
3. Серов В.Н., Торшин И.Ю., Громова О.А. Потриместровый подход к назначению витаминно-минеральных комплексов на основе систематического анализа биологической значимости витаминов и микроэлементов в системе мать-плацента-плод. Гинекология. 2010; 12(6): 24-34. [Serov V.N., Torshin I.Yu., Gromova O.A. A subprime approach to the designation of vitamin-mineral complexes based on a systematic analysis of the biological significance of vitamins and trace elements in the mother-placenta-fetus system. Ginekologiya. 2010; 12(6): 24-34. (in Russian)]
4. Burton G.J., Jauniaux E., Charnock-Jones D.S. Human early placental development: potential roles of the endometrial glands. Placenta. 2007;28(Suppl. A): S64-9.
5. Barker D.J., Thornburg K.L. Placental programming of chronic diseases, cancer and lifespan: a review. Placenta. 2013; 34(10): 841-5.
6. Ших Е.В., Ильенко Л.И. Клинико-фармакологические аспекты применения витаминно-минеральных комплексов в педиатрии. Учебное пособие. М.: Медпрактика-М; 2008. [Shikh E.V., Ilyenko L.I. Clinical and pharmacological aspects of the use of vitamin-mineral complexes in pediatrics. Tutorial. Moscow: Medpraktika-M; 2008 (in Russian)]
7. Crider K.S., Bailey L.B., Berry R.J. Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients. 2011; 3(3): 370-84.
8. Chang H., Zhang T., Zhang Z., Bao R., Fu C., Wang Z. et al. Tissue-specific distribution of aberrant DNA methylation associated with maternal low-folate status in human neural tube defects. J. Nutr. Biochem. 2011; 22(12): 1172-7.
9. Chiaffarino F., Ascone G.B., Bortolus R., Mastroia-Covo P., Ricci E., Cipriani S., Parazzini F. Effects of folic acid supplementation on pregnancy outcomes: a review of randomized clinical trials. Minerva Ginecol. 2010; 62(4): 293-301.
10. Shaw G.M., Carmichael S.L., Yang W., Siega-Riz A.M.; National Birth Defects Prevention Study. Periconceptional intake of folic acid and food folate and risks of preterm delivery. Am. J. Perinatol. 2011; 28(10): 747-52.
11. Surén P., Roth C., Bresnahan M., Haugen M., Hornig M., Hirtz D. et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA. 2013; 309(6): 570-7.
12. WHO. Guideline: Daily iron and folic acid supplementation in pregnant women. Geneva: World Health Organization; 2012.
13. Jagerstad M. Folic acid fortification prevents neural tube defects and may also reduce cancer risks. Acta Paediatr. 2012; 101(10): 1007-12.
14. Нормы физиологической потребности в витамине В9 в зависимости от возраста в России. Available at: http://docs.cntd.ru/document/1200076084 [Norms of physiological need for vitamin B9 depending on the age in Russia. Available at: http://docs.cntd.ru/document/1200076084 (in Russian)]
15. Shin J.S., Choi M.Y., Longtine M.S., Nelson D.M. Vitamin D effects on pregnancy and the placenta. Placenta. 2010; 31(12): 1027-34.
16. Brannon P.M., Picciano M.F. Vitamin D in pregnancy and lactation in humans. Annu. Rev. Nutr. 2011; 31: 89-115.
17. Thorne-Lyman A., Fawzi W.W. Vitamin D during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Paediatr. Perinat. Epidemiol. 2012; 26(1): 10.
18. Громова О.А., Торшин И.Ю., Тетруашвили Н.К., Сидельникова В.М. Нутрициальный подход к профилактике избыточной массы тела новорожденных. Гинекология. 2010; 12(5): 56-64. [Gromova O.A., Torshin I.Yu., Tetruashvili N.K., Sidelnikova V.M. Nutritional approach to the prevention of overweight in newborns. Gynecology. 2010; 12(5): 56-64. (in Russian)]
19. Maghbooli Z., Hossein-Nezhad A., Karimi F., Shafaei A.R., Larijani B. Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes Metab. Res. Rev. 2008; 24(1): 27-32.
20. Haugen M., Brantsaeter A.L., Trogstad L., Alexander J., Roth C., Magnus P. et al. Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology. 2009; 20(5): 720-6.
21. Merewood A., Mehta S.D., Chen T.C., Bauchner H., Holick M.F. Association between vitamin D deficiency and primary cesarean section. J. Clin. Endocrinol. Metab. 2009; 94(3): 940-5.
22. WHO. Guideline: Vitamin D supplementation in pregnant women. Geneva: World Health Organization; 2012: 3-5.
23. Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации. Методические рекомендации МР 2.3.1.2432-08. М.; 2009.
24. Williams G.R. Neurodevelopmental and neurophysiological actions of thyroid hormones. J. Neuroendocrinol. 2008; 20(6): 784-94.
25. Кочергина И.И. Профилактика и лечение дефицита йода и эндемического зоба. Русский медицинский журнал. 2009; 24(363): 1599. [Kochergina I.I. Prevention and treatment of iodine deficiency and endemic goiter. Russian medical journal. 2009; 24 (363): 1599. (in Russian)]
26. Stagnaro-Green A., Sullivan S., Pearce E.N. Iodine supplementation during pregnancy and lactation. JAMA. 2012; 308(23): 2463-4.
27. Zimmermann M.B. Iodine and iodine deficiency disorders. In: Erdman J.W.J., Macdonald I.A., Zeisel S.H., eds. Present knowledge in nutrition. 10th ed. Washington, D.C.: Wiley-Blackwell; 2012: 554-67.
28. Connelly K.J., Boston B.A., Pearce E.N., Sesser D., Snyder D., Braverman L.E. et al. Congenital hypothyroidism caused by excess prenatal maternal iodine ingestion. J. Pediatr. 2012; 161(4): 760-2.
29. Flock M.R., Skulas-Ray A.C., Harris W.S., Etherton T.D., Fleming J.A., Kris-Etherton P.M. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial. J. Am. Heart Assoc. 2013; 2(6): e000513.
30. Davidson P.W., Strain J.J., Myers G.J., Thurston S.W., Bonham M.P., Shamlaye C.F. et al. Neurodevelopmental effects of maternal nutritional status and exposure to methylmercury from eating fish during pregnancy. Neurotoxicology. 2008; 29(5): 767-75.
31. Лиманова О.А., Громова О.А., Торшин И.Ю., Волков А.Ю., Галустян А.Н., Гришина Т.Р., Керимкулова Н.В., Сардарян И.С., Сонина Н.П., Томилова И.К., Федотова Л.Э. Низкое потребление омега-3 полиненасыщенных жирных кислот и риск различных заболеваний у женщин репродуктивного возраста. РМЖ. 2018; 5(I). Доступно: https://www.rmj.ru/articles/ginekologiya/nizkoe-potreblenie-omega-3-polinenasyshchennykh-zhirnykh-kislot-i-risk-razlichnykh-zabolevaniy-u-zhe/
32. Hadders-Algra M. Prenatal long-chain polyunsaturated fatty acid status: the importance of a balanced intake of docosahexaenoic acid and arachidonic acid. J. Perinat. Med. 2008; 36(2): 101-9.
33. Davidson M.H. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid. Curr. Opin. Lipidol. 2013; 24(6): 467-74.
34. Yazdi P.G. A review of the biologic and pharmacological role of docosapentaenoic acid [version 1; referees: 2 approved with reservations]. F1000Research. 2013, 2: 256.
35. Cherhan C.N. Novel lipid mediators and resolutionmechanism in acute inflammationю Am. J. Pathol. 2010; 177(4): 1576-91.
36. Куликов В.А., Гребенников В.Н. Резольвины, протектины и марезины – новые медиаторы воспаления. Вестник Витебского государственного медицинского университета. 2012; 11(1): 25-30. [Kulikov V.A., Grebennikov V.N. Resolvins, protectins and marezins are new mediators of inflammation. Bulletin of Vitebsk State Medical University. 2012; 11(1): 25-30. (in Russian)]
37. See V.H.L., Mas E., Prescott S.L., Beilin L.J., Burrows S., Barden A.E. et al.Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial. Br. J. Nutr. 2017; 118(11): 971-80.
38. Ганчар Е.П., Кажина М.В., Яговдик И.Н. Клиническая значимость омега-3полиненасыщенных жирных кислот в акушерстве (обзор литературы). Журнал Гродненского государственного медицинского университета. 2012; 2: 7-10. [Ganchar E.P., Kazhina M.V., Yagovdik I.N. The clinical significance of omega-3 polyunsaturated fatty acids in obstetrics (literature review). Journal of Grodno State Medical University. 2012; 2: 7-10. (in Russian)]
39. Guesnet P., Alessandri J.M. Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) – Implications for dietary recommendations. Biochimie. 2011; 93(1): 7-12.
40. European Food Safety Authority. Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J. 2010;8(3):1–107. Available at: http://www.efsa.europa.eu
41. Rizos E.C., Ntzani E.E., Bika E., Kostapanos M.S., Elisaf M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012; 308(10): 1024-33.
42. Traber M.G. Vitamin E. In: Erdman JWJ, Macdonald IA, Zeisel SH, eds. Present knowledge in nutrition. 10th ed. Washington, D.C.: Wiley-Blackwell;2012: 214-29.
43. Boskovic R.L., Gargaun L., Oren D., Djulus J., Koren G. Pregnancy outcome following high doses of Vitamin E supplementation. Reprod Toxicol. 2005; 20(1): 85-8.
Received 22.08.2018
Accepted 21.09.2018
About the Authors
Shikh, Evgenia V., MD, Professor, Head of the Department of Clinical Pharmacology and Propedeutics of Internal Diseases, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia. 119991, Russia, Moscow, Bolshaya Pirogovskaya str. 2, bld. 4. E-mail: chih@mail.ruMakhova, Anna A., PhD, Associate Professor of the Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, I.M. Sechenov First Moscow State
Medical University (Sechenov University), Ministry of Health of Russia. 119991, Russia, Moscow, Bolshaya Pirogovskaya str. 2, bld. 4. E-mail: annabramova@gmail.com
For citations: Shikh E.V., Makhova A.A. The endemicity of an area in terms of micronutrient deficiencies as a criterion for compounding a basic vitamin-mineral complex for the periconceptional period. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2018; (10): 25-32. (in Russian)
https://dx.doi.org/10.18565/aig.2018.10.25-32
Similar Articles
